lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Trend of the Coronavirus Disease-2019 Epidemic in China After the Lockdown of Wuhan City on January 23, 2020

33 Pages Posted: 24 Mar 2020

See all articles by Feiqing Wang

Feiqing Wang

Guizhou University of Traditional Chinese Medicine - Department of Science and Education

Yanju Li

Guizhou Medical University (Guiyang Medical University) - Department of Hematology

Dongxin Tang

Guizhou University of Traditional Chinese Medicine - Department of Science and Education

Qinshan Li

Guizhou Medical University (Guiyang Medical University) - Department of Hematology

Guangyang Liu

Guizhou University of Traditional Chinese Medicine - Department of Science and Education

Jishi Wang

Guizhou Medical University (Guiyang Medical University) - Department of Hematology

Zhixu He

Zunyi Medical University - Department of Pediatrics; National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique

Songhua Zhao

Guizhou Center for Disease Control and Prevention - Health Monitoring and Testing Institute

Jide Jin

Academy of Military Sciences - Institute of Radiation Medicine

Chu-tse Wu

Academy of Military Sciences - Institute of Radiation Medicine

Yang Liu

Guizhou University of Traditional Chinese Medicine - Department of Science and Education; National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique

More...

Abstract

Background: The Chinese Government decided to quarantine Wuhan, the epicenter of the coronavirus disease-2019 (COVID-19) outbreak, on January 23, 2020, to control the spread of the epidemic. We analyzed the data on incidence, severity, deaths, and recovered of COVID-19 across the whole country, in Hubei province, and in the other provinces, to identify the incubation period of the disease and the inflection point of the epidemic.

Methods: We analyzed the data released by the Health Commission of Hubei Province and the National Health Commission (NHC) of the People’s Republic of China from January 23 to March 1, 2020. We examined the following: cumulative number of confirmed cases and daily new confirmed cases, total number of severe cases in hospital and daily number of new severe cases, cumulative number of deaths and daily deaths, cumulative number of recovered cases and daily new recovered cases, total number of suspected cases, cumulative number of close contacts, cumulative number removed from medical observation and number receiving medical observation.

Results: From January 23 to March 1, 2020, 80,026 confirmed cases were reported in the whole country, with 67,103 (83·7%) cases reported from Hubei province and 12,923 (16·3%) cases from the other provinces. After the lockdown of Wuhan city, the number of confirmed cases reported daily continued to increase and peaked on February 4. From February 5 to March 1, the number of cases gradually decreased by 85·0% in the whole country, 83·2% in Hubei province, and 92·8% in the other provinces. The number of deaths continues to increase because of the large number of severe cases in hospitals. The severe case rate was 18·3% in the whole country, 19·3% in Hubei province, and 12·7% in other provinces. The case fatality rate was 3·6% in the whole country, 4·2% in Hubei province, and 0·8% in the other provinces. Cumulative recovery rate was 55·6% in the whole country, 50·5% in Hubei province, and 80·2% in the other provinces. Case fatality was high in patients aged above 60 years (mortality >80%), males (mortality 76·5%), and patients with comorbidities (mortality 64·7%).

Conclusions: The lockdown of Wuhan city appears to have been effective in controlling the spread of the epidemic. The inflection point appeared on February 4, and since then the number of new cases has fallen sharply. The highest risk of mortality appears to be in elderly males with comorbidities. The mortality rates may continue to rise because of the large number of seriously ill patients in hospitals. However, the recovery rate can be expected to rise sharply as new treatments are introduced.

Funding Statement: This study was supported by the National Natural Science Foundation of China (No. 31660326); Natural Science Foundation of Guizhou Province (No. [2018]1015, [2018]2759, [2017]5735, and [2016]1019); Top Talent Foundation of the Department of Education of Guizhou Province (No. [2016]074); Natural Science Foundation of Guiyang City (No. [2019]9-2-2, [2019]9-2-22); Doctoral Foundation of the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine (No. GYZYYFY-BS-2018[12]); and China Postdoctoral Science Foundation (No. 2018M640938 and 43XB3794XB).

Declaration of Interests: The authors declare no competing interests.

Keywords: COVID-19; Inflection period; Severe case rate; Fatality rate; Recovery rate

Suggested Citation

Wang, Feiqing and Li, Yanju and Tang, Dongxin and Li, Qinshan and Liu, Guangyang and Wang, Jishi and He, Zhixu and Zhao, Songhua and Jin, Jide and Wu, Chu-tse and Liu, Yang, Trend of the Coronavirus Disease-2019 Epidemic in China After the Lockdown of Wuhan City on January 23, 2020 (3/12/2020). Available at SSRN: https://ssrn.com/abstract=3555218 or http://dx.doi.org/10.2139/ssrn.3555218

Feiqing Wang (Contact Author)

Guizhou University of Traditional Chinese Medicine - Department of Science and Education ( email )

Guiyang
China

Yanju Li

Guizhou Medical University (Guiyang Medical University) - Department of Hematology

Guiyang
China

Dongxin Tang

Guizhou University of Traditional Chinese Medicine - Department of Science and Education

Guiyang
China

Qinshan Li

Guizhou Medical University (Guiyang Medical University) - Department of Hematology

Guiyang
China

Guangyang Liu

Guizhou University of Traditional Chinese Medicine - Department of Science and Education

Guiyang
China

Jishi Wang

Guizhou Medical University (Guiyang Medical University) - Department of Hematology

Guiyang
China

Zhixu He

Zunyi Medical University - Department of Pediatrics

Zunyi
China

National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique

Guiyang
China

Songhua Zhao

Guizhou Center for Disease Control and Prevention - Health Monitoring and Testing Institute

Guiyang
China

Jide Jin

Academy of Military Sciences - Institute of Radiation Medicine

Beijing
China

Chu-tse Wu

Academy of Military Sciences - Institute of Radiation Medicine

Beijing
China

Yang Liu

Guizhou University of Traditional Chinese Medicine - Department of Science and Education ( email )

Guiyang
China

National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique

Guiyang
China

Click here to go to TheLancet.com

Paper statistics

Abstract Views
915
Downloads
133